Related Experiment Video
Updated: May 2, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Focal bone lesions in HIV-positive patient treated with tenofovir
Davide Mangioni, Alessandra Bandera, Antonio Muscatello
1Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy. andrea.gori@unimib.it.
Background:
Tenofovir is a widely used antiviral drug for the treatment of HIV and HBV infection. Although its side effects on renal function and bone metabolism are well known, there are no reports on focal bone lesions caused by this drug. Our case suggests this new, unusual but important scenario.
Case Presentation:
We report on a 46-year-old HIV-positive man treated with an antiretroviral regimen containing tenofovir who suddenly developed localized inflammatory bone lesions. The examinations performed ruled out all the disorders commonly associated with this clinical pattern, and the patient's conditions improved only after the suspension of tenofovir.
Conclusions:
The case study suggests a rare but severe adverse event, which should be taken into account when physicians treat HIV-positive patients with focal inflammatory bone lesions.
Related Concept Videos
Retroviruses
Cytomegalovirus Disease
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Hepatitis
Retrovirus Life Cycles

